Genomic Health, Inc. (GHDX) Tops Q4 EPS by 3c, Guides FY13
Tweet Send to a FriendGet Alerts GHDX Hot Sheet
Price: $34.05 +3.28%
Revenue Growth %: +7.0%
Financial Fact:
Income tax expense: 53K
Today's EPS Names:
CO, JW-A, FDS, More
Revenue Growth %: +7.0%
Financial Fact:
Income tax expense: 53K
Today's EPS Names:
CO, JW-A, FDS, More
Trade GHDX Now!
Genomic Health, Inc. (NASDAQ: GHDX) reported Q4 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $60.4 million versus the consensus estimate of $58.9 million.
Genomic Health, Inc. sees FY2013 revenue of $258-266 million, versus the consensus of $262.40 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Genomic Health, Inc. sees FY2013 revenue of $258-266 million, versus the consensus of $262.40 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
